| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 77108337 | FILING DATE | 02/15/2007 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | REGAN, JOHN B |
L.O. ASSIGNED | 113 |
PUB INFORMATION |
|||
| RUN DATE | 09/14/2010 | ||
| PUB DATE | 12/16/2008 | ||
| STATUS | 732-THIRD EXTENSION - GRANTED | ||
| STATUS DATE | 09/13/2010 | ||
| LITERAL MARK ELEMENT | AILERON | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | AILERON |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Aileron Therapeutics, Inc. |
| ADDRESS | 840 Memorial Drive Cambridge, MA 02139 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | pharmaceutical compositions, namely, preparations for the treatment of cancer, diabetes, neurodegenerative disorders, cardiovascular disease and disorders, metabolic syndrome, autoimmune disorders, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, hypertension, erectile dysfunction, sexual dysfunction, stroke, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological disorders, anxiety, depression, neuropsychiatric disorders including both psychotic and non-psychotic conditions, and substance abuse disorders, including both abuse and dependence, disorders of blood cell production, organ transplant rejection, endocrinologic disorders, and bacterial, viral and fungal diseases; diagnostic products, namely, medical diagnostic reagents, diagnostic reagents for clinical or medical laboratory use; biological reagents for medical purposes in the field of molecular biology; and reagents for use in biological processing for medical purposes |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 09/14/2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 042 |
| 09/13/2010 | EX3G | S | EXTENSION 3 GRANTED | 041 |
| 09/10/2010 | EXT3 | S | EXTENSION 3 FILED | 040 |
| 09/10/2010 | EEXT | I | TEAS EXTENSION RECEIVED | 039 |
| 04/06/2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 038 |
| 04/05/2010 | EX2G | S | EXTENSION 2 GRANTED | 037 |
| 03/10/2010 | EXT2 | S | EXTENSION 2 FILED | 036 |
| 04/05/2010 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 035 |
| 03/10/2010 | EEXT | I | TEAS EXTENSION RECEIVED | 034 |
| 09/10/2009 | EX1G | S | EXTENSION 1 GRANTED | 033 |
| 09/10/2009 | EXT1 | S | EXTENSION 1 FILED | 032 |
| 09/10/2009 | EEXT | I | TEAS EXTENSION RECEIVED | 031 |
| 03/10/2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | 030 |
| 12/16/2008 | PUBO | A | PUBLISHED FOR OPPOSITION | 029 |
| 11/26/2008 | NPUB | O | NOTICE OF PUBLICATION | 028 |
| 11/10/2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 027 |
| 11/07/2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 026 |
| 11/07/2008 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 025 |
| 11/07/2008 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 024 |
| 11/07/2008 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 023 |
| 11/07/2008 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 022 |
| 07/10/2008 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | 021 |
| 07/10/2008 | GNFR | O | FINAL REFUSAL E-MAILED | 020 |
| 07/10/2008 | CNFR | R | FINAL REFUSAL WRITTEN | 019 |
| 06/24/2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 018 |
| 06/24/2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 017 |
| 06/24/2008 | ALIE | A | ASSIGNED TO LIE | 016 |
| 06/24/2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 015 |
| 02/20/2008 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 014 |
| 02/20/2008 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | 013 |
| 12/26/2007 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | 012 |
| 12/26/2007 | GPRA | O | PRIORITY ACTION E-MAILED | 011 |
| 12/26/2007 | CPRA | R | PRIORITY ACTION WRITTEN | 010 |
| 12/14/2007 | ARAA | I | ATTORNEY REVOKED AND/OR APPOINTED | 009 |
| 12/14/2007 | REAP | I | TEAS REVOKE/APPOINT ATTORNEY RECEIVED | 008 |
| 12/06/2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 007 |
| 12/04/2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 006 |
| 12/04/2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 005 |
| 06/06/2007 | CNRT | F | NON-FINAL ACTION MAILED | 004 |
| 06/06/2007 | CNRT | R | NON-FINAL ACTION WRITTEN | 003 |
| 06/05/2007 | DOCK | D | ASSIGNED TO EXAMINER | 002 |
| 02/21/2007 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Aaron Hendelman |
| CORRESPONDENCE ADDRESS | Aaron Hendelman Wilson Sonsini Goodrich & Rosati 650 Page Mill Road Palo Alto CA 94303 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Aileron Therapeutics, Inc. |
| ADDRESS | 840 Memorial Drive Cambridge, MA 02139 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |